US Stock MarketDetailed Quotes

ALKS Alkermes

Watchlist
  • 24.420
  • -0.590-2.36%
Close Jun 18 16:00 ET
  • 24.420
  • 0.0000.00%
Post 17:02 ET
4.13BMarket Cap9.54P/E (TTM)

About Alkermes Company

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

Company Profile

SymbolALKS
Company NameAlkermes
Listing DateSep 19, 2011
Issue Price10.00
Founded2011
CEOMr. Richard F. Pops
MarketNASDAQ
Employees2100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressConnaught House,1 Burlington Road
CityDublin
ProvinceDublin
CountryIreland
Zip Code4
Phone353-1-772-8000
Websitehttp://www.alkermes.com

Company Executives

  • Name
  • Position
  • Salary
  • Richard F. Pops
  • Chairman of the Board and Chief Executive Officer
  • 9.44M
  • Iain M. Brown
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 3.21M
  • Christian Todd Nichols
  • Senior Vice President and Chief Commercial Officer
  • --
  • Dr. Craig C. Hopkinson, M.D.
  • Executive Vice President, Research and Development and Chief Medical Officer
  • 4.73M
  • David Joseph Gaffin
  • Executive Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer
  • 4.14M
  • Blair C. Jackson
  • Interim Chief Financial Officer; Executive Vice President and Chief Operating Officer of the Company and Alkermes, Inc.
  • 4.56M
  • Samuel J. Parisi
  • Interim Principal Accounting Officer; Vice President, Finance of Alkermes, Inc.
  • --
  • Shane M. Cooke
  • Chairman of the Board; Alkermes Pharma Ireland Limited
  • 449.04K
  • David A. Daglio, Jr
  • Independent Director
  • 474.04K
  • Dr. Christopher I. Wright, M.D.,PhD
  • Independent Director
  • 463.12K
  • Dr. Cato T. Laurencin,M.D.,PhD
  • Independent Director
  • 459.04K
  • Nancy S. Lurker
  • Independent Director
  • --
  • Dr. Nancy L. Snyderman, F.A.C.S.,M.D.
  • Independent Director
  • 482.04K
  • Brian P. Mckeon
  • Independent Director
  • 482.04K
  • Frank Anders Wilson
  • Lead Independent Director
  • 486.65K
  • Emily Peterson Alva
  • Independent Director
  • 469.04K
  • Dr. Richard B. Gaynor, M.D.
  • Independent Director
  • 464.69K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg